# Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections

> **NCT05988177** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Carbapenem Resistant Bacterial Infection
- Hemophagocytic Lymphohistiocytoses

## Interventions

- **DRUG:** Carrimycin tablets

## Key facts

- **NCT ID:** NCT05988177
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-08-30
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05988177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05988177, "Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05988177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*